Global Health Limited has announced its participation in scheduled analyst and institutional investor meetings organized by ICICI Securities Limited for March 2026. The company issued the regulatory intimation on March 18, 2026, in compliance with SEBI listing obligations under reference number GHL/2025-26/EXCH/112.

Meeting Schedule and Details

The healthcare company has confirmed its management's participation in group meetings with investors and analysts during the last week of March 2026. The meetings are being organized by ICICI Securities Limited and will be conducted in-person at two different locations.

Regulatory Compliance and Information Sharing

The company has emphasized its commitment to regulatory compliance in the official announcement. Global Health Limited specifically stated that no unpublished price sensitive information is proposed to be shared during these investor interactions. This disclosure aligns with SEBI regulations governing information sharing in investor meetings.

The meetings are being conducted pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The regulatory filing was addressed to both BSE Limited and National Stock Exchange of India Limited, with Company Secretary and Compliance Officer Rahul Ranjan signing the document on March 18, 2026.

Meeting Flexibility and Contingencies

Global Health Limited has included a provision for potential schedule modifications in its announcement. The company noted that the meeting schedule remains subject to change in case of unforeseen circumstances on the part of analysts, investors, or the company itself. This flexibility clause provides accommodation for any last-minute adjustments that may be required by participating parties.

The formal communication was sent to the General Manager of BSE Limited's Department of Corporate Services and the Manager of NSE's Listing Department, ensuring proper regulatory notification across both major Indian stock exchanges.

Global Health Limited has successfully concluded its postal ballot process, announcing comprehensive voting results on March 14, 2026. The company secured shareholder approval for all three resolutions presented during the remote e-voting process that concluded on March 13, 2026.

Postal Ballot Overview

The postal ballot was conducted under the supervision of scrutinizer Mr. Mukesh Kumar Agarwal from Mukesh Agarwal & Co., Practicing Company Secretaries. The remote e-voting process concluded on March 13, 2026 at 5:00 PM, with the scrutinizer submitting his report on March 14, 2026.

Resolution Results Summary

All three resolutions presented to shareholders achieved the required majority for approval. The voting demonstrated strong support from both promoter groups and public shareholders across institutional and non-institutional categories.

Resolution 1: Dr. Ravi Gupta Re-appointment

The special resolution for re-appointment of Dr. Ravi Gupta (DIN: 00023487) as Independent Director received overwhelming support:

Resolution 2: Mr. Rajan Bharti Mittal Re-appointment

The special resolution for re-appointment of Mr. Rajan Bharti Mittal (DIN: 00028016) as Independent Director also secured strong approval:

Resolution 3: Ms. Shonan Purie Trehan Appointment

The ordinary resolution for appointment of Ms. Shonan Purie Trehan (DIN: 07078955) as Non-Executive Non-Independent Director achieved the highest approval rate:

Regulatory Compliance and Communication

The company has communicated the postal ballot results to both BSE Limited and National Stock Exchange of India Limited through official correspondence dated March 14, 2026. Company Secretary Rahul Ranjan submitted the voting results in compliance with Regulation 44 and 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The voting results and consolidated scrutinizer's report have been uploaded on the company's investor relations website and the National Securities Depository Limited's e-voting platform. The postal ballot notice was dispatched electronically to all eligible shareholders on February 10, 2026, with advertisements published in Financial Express and Jansatta newspapers on February 11, 2026.

Voting Process Details

Key voting statistics showed strong participation with 89.77% of outstanding shares participating in the voting process across all three resolutions. The votes were unblocked on March 13, 2026 at 5:23 PM in the presence of two independent witnesses. The company fulfilled all regulatory requirements ensuring complete transparency in the postal ballot process.